#47 - 600% in 3 Days: the execution playbook behind Abivax’s breakthrough in IBD
Épisode de Pharma Minds par Nathalie Lahitte · 8 décembre 2025 · 59 min
“Within three days, we went from almost bankrupt… to one of the stars of the Nasdaq.”
In this conversation, I take you behind the scenes of a biotech journey that sounds almost unbelievable.
Marc de Garidel, CEO of Abivax, tells me how he rebuilt this French biotech from scratch, designed a strategy powerful enough to attract top US investors and executed one of the largest phase 3 programs in ulcerative colitis: a molecule from French public research (CNRS, Institut Curie and the University of Montpellier) which may have a major impact on patients.
This episode is a masterclass in leadership, execution, courage, and long-term thinking.
Here’s what you’ll hear about in this episode:
◾️ How Marc stepped into a company with almost no long-term plan… and why that turned out to be a surprising advantage.
◾️ The four pillars of a new strategy — and how one of them quietly set the stage for the breakthrough to come.
◾️ What it really takes to run a global phase 3 across dozens of countries — and why Abivax had to reinvent itself to pull it off.
◾️ A mechanism of action unlike anything else in IBD — and why this difference matters more than most people think.
◾️ The hidden lessons from a noisy phase 2 that helped transform the phase 3 into something no one saw coming.
◾️ A leadership philosophy built on transparency and speed, born from a single principle: in biotech, every day counts.
◾️ The unexpected market reaction that changed the fate of the company overnight — with numbers that almost don’t seem real.
If you want to hear a real behind-the-scenes story, hit play.
This episode is an exceptional inside look at what it truly takes to turn science into impact, stand your ground under pressure, and lead a biotech from survival… to breakthrough.
—
Find Marc de Garidel:
LinkedIn: https://www.linkedin.com/in/marc-de-garidel-097982/
—
Resources mentioned in the episode:
Abivax https://www.abivax.com/
Pharma Minds episodes mentioned:
His first interview in Pharma Minds in 2023: “CEO Marc De Garidel On Building Something Truly Impactful: Embrace Risks!” https://www.youtube.com/watch?v=mA3-OSltbwQ (in English)
—
🎧 New here? To get a quick overview of the episodes, download “25 Tips for Purposeful Leadership”, a guide inspired by the best advice shared by my guests.
🤝 Want to connect or talk about your current challenges? Let’s connect on LinkedIn.
📩 Curious to dive deeper into the major shifts in the healthcare ecosystem? Subscribe to the Pharma Minds newsletter.
Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.
Autres épisodes de « Pharma Minds »
- #53 - Libérer du temps soignant : le pari d'un ingénieur à la Clinique Pasteur 19 octobre 2026
- [EXTRAIT] « On a toujours fait comme ça » : comment faire accepter le changement ? avec Loïc Lagarde 18 octobre 2026
- "Europe's Access Dilemma" (BONUS) - The Innovation Wave? Europe’s Payers Aren’t Convinced 12 octobre 2026
- "Europe's Access Dilemma" (5/5) - "Germany has a target on its back" What will Europe give up? 5 octobre 2026
- "Europe's Access Dilemma" (4/5) - Pharma Innovation: Your 8-Year Competitive Window Is Now Just 3 28 septembre 2026
- "Europe's Access Dilemma" (3/5) - MFN Is Already Changing Pharma Launch Strategy. Here’s How to Prepare. 21 septembre 2026
- "Europe's Access Dilemma" (2/5) - Europe Can't Pay More For Innovation: The Case For Co-developing With Asia 14 septembre 2026
- "Europe's Access Dilemma" (1/5) - Europe Is Losing Access to New Medicines. Here’s Why. 7 septembre 2026
- [Insights] Produits frontières : transformer la réglementation en avantage stratégique 2 septembre 2026
- "Executing differently takes courage" (5/5) - From managing global subsidiaries to walking the talk : when execution becomes personal 17 août 2026
- "Executing differently takes courage" (4/5) - Biotech survival and resource allocation : why execution is about choosing what not to do 10 août 2026
- "Executing differently takes courage" (3/5) - Trusting the ground : navigating volatility, growth and partnerships across the EEMEA zone 3 août 2026
- "Executing differently takes courage" (2/5) - The Chinese pharma ecosystem : balancing systemic scale and constant reinvention 27 juillet 2026
- "Executing differently takes courage" (1/5) Transforming Vidal : how a 20-year vision turned a paper book into digital infrastructure 20 juillet 2026
- [Insights] Groupements de pharmacies : ce qu’il faut retenir du rapport IGF-IGAS, avec Hugues Villey Desmeserets 8 juillet 2026
À propos du podcast
Bienvenue dans Pharma minds, le podcast qui vous emmène dans une aventure captivante à travers la Pharma et la Santé d'aujourd'hui ! Je suis votre hôte, Nathalie Lahitte. Mon objectif ? Découvrir comment des personnalités influentes ont contribué à façonner ce secteur. À chaque épisode, nous…
Épisodes similaires
- Radio et DAB+ : y aura-t-il un jour de la vidéo FM ? – Ça marque ! Le podcast qui décrypte les stratégies de communication digitale et les innovations du marketing éditorial
- Webinaire / découvrir les ETF avec Amundi : comprendre, choisir et investir – Webinaire
- Arrêt maladie, Indemnités limitées à un an : ces enjeux RH que les DRH doivent poser sur la table du CoDir dès maintenant – Capital Humain – Travail, ressources humaines et santé mentale
- [AZIMUT ENTREPRENDRE | 1/3] - 15 000 abonnés sans montrer son visage - Safia Hadidi – Donne le Rythme
- Bénédicte Henry, sa foi, <br>ses convictions et engagements – Les rencontres du père Jacques Thierry
- 1000 ads en une semaine : comment Flytex scale ses ads Meta avec l'IA – Le Rendez-vous E-commerce
Tous les épisodes de Pharma Minds · Plus de podcasts Business